

Cover Story
Free
By Alexandria Carolan
A sense of foreboding descended on Narjust Duma as she sat at a presentation on drug-induced toxicities. The year was 2018, Duma was a 31-year-old second-year fellow at Mayo Clinic, and her discomfort stemmed from something other than the subject matter discussed.
In Brief


Clinical Roundup
Drugs & Targets
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Vermont researchers discover transmissible cancer in catfish—first ever in a freshwater animal
- The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Patricio Polanco named chief of surgical oncology and surgeon-in-chief at Atrium Health Levine Cancer














